Published

Effects of Psilocybin and Select Pharmaceutical Interactions

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: MacEwan University Student eJournal
Date: 2026-02-18
Source: OpenAlex
DOI: 10.31542/bcek6t76
PubMed: Unavailable

Authors

Jordan McDowell Jada Middleton Alanna Bluett Alisa Kozachenko Bayan Attar Yuvraj Singh Saini Jennifer Burke Cayden McPhee Mutahera Mutahera Talya Ahmed Nabila Ibrahim Gilbert Atukwatsibwe Sulabha Adhikari Mohammad Esmaili Jean-Vital Yambayamba

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Pharmacology Receptor Pharmacology Aging Clinical Trial Older Adults Toxicity Drug Interactions Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Effects of Psilocybin and Select Pharmaceutical Interactions2026-02-18

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-19 Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy SubjectsClinicalTrials.gov · 2024-01-24 Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial.Trials · 2024-05-21 Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2020-12-01 A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderClinicalTrials.gov · 2025-08-19 Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)ClinicalTrials.gov · 2025-05-28 Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of ConsciousnessClinicalTrials.gov · 2023-03-29